HDAC9 and infection: Among the anti‐correlated conditions are 4 compounds that could potentially interfere with the infection process or the host response: SB202190 (p38 MAP kinase inhibitor), mesalazine (anti‐inflammatory), trichostatin A (HDAC inhibitor), and verapamil (an efflux pump inhibitor).